The Effect of Intensive and Short-term Insulin Treatment on Long-term Pancreatic beta-cell Function in Newly Diagnosed People With Type 2 Diabetes in Korea.

Trial Profile

The Effect of Intensive and Short-term Insulin Treatment on Long-term Pancreatic beta-cell Function in Newly Diagnosed People With Type 2 Diabetes in Korea.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2013

At a glance

  • Drugs Glimepiride (Primary) ; Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms KIIT
  • Most Recent Events

    • 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 18 Aug 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 30 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top